Simmons & Simmons partner Tony Woodgate and colleague Ilaria Filippi discuss the implications of the ECJ AstraZeneca judgment for dominant companies.

Simmons &amp; Simmons partner Tony Woodgate and colleague Ilaria Filippi discuss the implications of the ECJ AstraZeneca judgment for dominant companies.

Episode 282: Dominant companies and normal competition

Description elexica is the award winning, free online legal resource created by leading international law firm Simmons & Simmons LLP.

Business

Description elexica is the award winning, free online legal resource created by leading international law firm Simmons &amp; Simmons LLP.

Share Episode 282: Dominant companies and normal competition

Sign up to save your podcasts

Episode 282: Dominant companies and normal competition

Episode 282: Dominant companies and normal competition